You are invited to attend ASIPP's 23rd Annual Meeting, June 24-26 in NOLA!
|
|
Topics will include COVID-19, ECONOMICS, BURNOUT, SOCIAL MEDIA, METABOLIC HEALTH, REGULATORY ISSUES, SCIENTIFIC ADVANCES
in IPM, and MUCH MORE!
|
|
The ASIPP Annual Meeting will feature
THREE INNOVATION SUMMITS during the afternoon breakout sessions each day.
Learn about the
LATEST TECHNOLOGICAL ADVANCEMENTS
to help you in your practice.
Multiple technologies will be highlighted in the areas of SPINAL CORD STIMULATION,
PERIPHERAL NERVE STIMULATION, and
MINIMALLY INVASIVE TECHNOLOGIES.
|
|
"We should move to global budgets as soon as possible," says Donald Berwick
If the U.S. wants to give everyone access to healthcare, fee-for-service medicine has to go, Donald Berwick, MD, former president of the Institute for Healthcare Improvement, said at a webinar on value-based care sponsored by the Duke Margolis Center for Health Policy.
"We should move to global budgets as soon as possible," Berwick said at Thursday's event. "It will not happen in a fee-for-service environment; I just don't believe it can. And so the more we get to funding organizations to give total care to populations, the better."
Berwick, who served as acting administrator of the Centers for Medicare & Medicaid Services under President Obama, also had other suggestions for improving the healthcare system. "There should be continuous cost reduction -- not [just] slowing the rate of rise. We should aim, I think, for 15% of GDP, as the healthcare goal, and any change that doesn't put us on that trajectory, doesn't reflect the best of us." The U.S. currently spends about 18% of its GDP -- $3.8 trillion -- on healthcare.
|
|
Experts discuss practical implications of a natural or accidental introduction for the virus
As interest grows in the hypothesis that SARS-CoV-2 may have escaped from the Wuhan Institute of Virology in China, more scientists are taking it seriously, in part because of the practical implications associated with it.
While many experts interviewed for this story were hesitant to speculate on the exact implications of a lab leak, they agreed that further research into the virus' origins is necessary, considering practical implications now may help forestall future pandemics.
|
|
A ransomware attack on a national hospital chain nearly brought Las Vegas hospitals to their knees. Another attack in Oregon abruptly shut down alerts tied to patient monitors tracking vital signs. In New York, one county’s only trauma center briefly closed to ambulances, with the nearest alternative 90 miles away.
Multiple attacks were carried out in recent months against U.S. hospitals, suspending some surgeries, delaying medical care and costing hospitals millions of dollars.
The Wall Street Journal tracked the most disruptive attacks to one group: a notorious gang of Eastern European cybercriminals once called the “Business Club,” with ties to Russian government security services, according to threat analysts and former law-enforcement officials who closely follow Eastern European cybercrime operations.
|
|
The agency's recent decision to approve aducanumab offers more evidence of a broken system
FDA's recent approval of a controversial drug -- aducanumab (Aduhelm) -- to treat people living with Alzheimer's disease shows just how broken the agency is, and reminds us that we all have to pay for it.
A series of events that has unfolded since January tells the story.
In late April, the FDA's Oncologic Drugs Advisory Committee reviewed six accelerated approvals -- a provisional pathway -- involving a group of cancer immunotherapies where clinical trials had failed to confirm that the drugs extended survival or improved quality of life. Yet, in four of the six cases, the advisory committee voted to keep the accelerated approvals intact. The lesson was painfully clear: once the toothpaste is out of the tube it is hard to get it back in. Once doctors get used to using a therapy, pulling a drug from the market or in this case, revoking indications, is hard -- even after the drugs fail to confirm benefit.
|
|
Annual report to Congress also looks at access to care in rural areas
Medicare needs to streamline its portfolio of alternative payment models (APMs), the Medicare Payment Advisory Commission (MedPAC) said Tuesday in its annual report to Congress.
"CMS [the Centers for Medicare & Medicaid Services] is to be commended for the vigor with which it has approached its mandate of implementing a wide variety of APMs over the last 10 years," MedPAC said in its report. "The strategy of implementing a plethora of models over the last decade has given the agency an opportunity to build up the evidence base about what works and what does not. While this strategy has yielded valuable information, the commission contends that continuing to test a large number of independent APMs is likely to inhibit the ability of APMs to reach their full potential. We therefore recommend that CMS now take a more holistic approach that involves implementing a smaller, more harmonized portfolio of APMs."
|
|
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer-review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
|
|
| CASE REPORT |
Samuel P. Ang, MD, Martha L. Castro, MD, Michael Montuori, MD,
Feza Remzi, MD, Shengping Zou, MD, and Steven Calvino, MD
Abstract
BACKGROUND: Inflammatory Bowel Disease (IBD) is often associated with significant abdominal pain that can be challenging to control. Although controversial, opioids are often prescribed for the management of abdominal pain in patients with IBD. There have been several methods described for the rapid taper of patients on long-term, high-dose opioids. However, to date, there have been no reported cases using epidural analgesia for rapid opioid taper.
CASE REPORT: We present a case of a 36-year-old man with ulcerative colitis and recurrent bowel obstructions on a high-dose transdermal fentanyl patch whose opioid consumption was rapidly tapered during inpatient hospitalization utilizing thoracic epidural analgesia.
|
|
| RETROSPECTIVE STUDY |
Xinyi Wang, BPharm, Sujita W. Narayan, PhD, Jonathan Penm, PhD, Charlotte Johnstone, MBChB, and Asad E. Patanwala, PharmD
Abstract
BACKGROUND: Tapentadol has relatively less effect on mu-opioid receptors compared with other opioids. This has the potential to reduce the occurrence of gastrointestinal (GI) adverse drug events (ADEs).
OBJECTIVES: To compare the GI ADEs during hospitalization between tapentadol immediate release (IR) and oxycodone IR following orthopedic surgeries.
|
|
| LITERATURE REVIEW |
Henny Azmanov, MD, Edgar L. Ross, MD, and Yaron Ilan, MD
Abstract
BACKGROUND: Control of chronic pain and mainly the partial or complete loss of response to analgesics is a major unmet need. Multiple mechanisms underline the development of tolerance to analgesics in general and specifically to opioids. The autonomic nervous system (ANS) plays a role in the development of analgesic tolerance and chronobiology.
OBJECTIVES: To review the mechanisms associated with the development of nonresponsiveness to analgesics.
|
|
Great News!
The Annual Meeting of the
Ohio & Kentucky Societies of
Interventional Pain Physicians is back!
Designated for 15 AMA PRA Category 1 Credits™
|
|
|
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Norcal Mutual is 'A' Rated by AM best and is license in all 50 states. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary award-winning risk management CME activities, click here.
|
|
ASIPP® is now offering our members the benefit of a unique revenue cycle management/ billing service. We have received a tremendous amount of interest in the ASIPP® billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
|
|
|
|
CALSIPP
Registration
and Agenda
COMING SOON!
|
|
up-to-date news related to you, your practice, and your patients!
|
|
|
|
|
|
|